Medical Affairs Fellowships
Mercer University College of Pharmacy has partnered with Arbor Pharmaceuticals and Galt Pharmaceuticals to offer two separate Medical Affairs Fellowships in Atlanta, GA. Representatives from Mercer, Arbor and Galt will have a booth at the December 2019 ASHP Midyear Clinical Meeting and Exhibition. Please register for a meeting time through the Personnel Placement Service.
Fellows will divide their time between the College and their respective pharmaceutical company, where they will help advance the clinical development of various products and support medical and scientific affairs as products move from development to commercialization. These fellowships are primarily designed to provide the candidate with in-depth experience in medical affairs and will focus on development of skills that will be valuable as graduates transition into a career in the pharmaceutical industry. Fellows will also have the opportunity to work with Mercer faculty on research projects. In addition, they will have opportunity to participate in teaching activities in the College’s Doctor of Pharmacy (Pharm.D.) didactic program.
Applications from candidates with a Pharm.D. degree or a graduate degree are sought for the July 2020 - June 2021 cycle. Applications should include a letter of intent, curriculum vitae, official transcripts and letters of recommendation from two references. Applications should be addressed to Dr. Bobby Jacob.
Applicants must send applications to Dr. Bobby Jacob by Friday, December 20, 2019.
Arbor Pharmaceuticals is a specialty pharmaceutical company that markets more than 20 FDA-approved products in multiple therapeutic areas, including cardiovascular, neuroscience, pediatric, endocrinology and hospital markets. Arbor was acquired by Mercer alumnus Ed Schutter, BSPHARM ‘77, MBA, and two other investors in 2010. Since acquisition, the company has grown from less than $2 million in annual sales to more than $300 million. The company is led by a management team with extensive pharmaceutical industry experience in clinical development, medical and regulatory affairs, manufacturing, quality control and commercialization.
The company currently employs numerous MDs, PhDs, PharmDs, nurses and other scientists who work in medical, clinical or regulatory affairs, manufacturing, quality control, managed markets and commercial operations. Fellows will work primarily within our medical department, led by Evan Scullin, M.D., along with Mercer alumna Rebecca Neal Burns, PHARM ’12, PHD ’12. Fellows will likely be involved in projects ranging from pharmacoeconomic analysis of products, drug safety investigations and research of new development or in-licensing opportunities. For more information regarding Arbor Pharmaceuticals or any of its products, please visit www.arborpharma.com.
Applicants attending ASHP 2019 must sign-up for PPS and submit materials thru the portal. Applicants unable to attend ASHP must email materials to Dr. Bobby Jacob by Friday, December 6, 2019.
Galt Pharmaceuticals is a unique pharmaceutical company that seeks to serve unmet needs within health care. The company applies pharmaceutical, managed care and marketing expertise to develop, license and acquire pharmaceutical products for distribution, partnering with independent pharmacies to deliver patient-centered, community-driven care. Galt is the first and only pharmaceutical company to utilize a franchise model, trademarked as “phranchise,” allowing for entrepreneurs the opportunity to build their own pharmaceutical business locally, rather than the centralized, corporate model of traditional pharma.
The fellowship is a one-year experience concentrated in medical affairs, involving various experiences in medical information, scientific communications and field medical support. Fellows also will have the opportunity to be involved in cross-functional projects with regulatory, marketing and commercial operations. In addition, the chosen applicant will work alongside Galt’s two cofounders, CEO Barry Patel, PHARMD ‘92, who co-founded and later sold the pharmaceutical outcomes research and education company Total Therapeutic Management and chairman Wade Smith, PHARMD ‘88, both of whom are Mercer graduates.